This Biotech Just Catapulted 33%, Flashing A Bullish Sign
expanded its gene therapy collaboration with Voyager Therapeutics (VYGR) on Tuesday. VYGR stock rocketed above its 200-day line for the first time in four months. The two companies will work together to test gene therapies for Huntington's disease and spinal muscular atrophy. Both inherited…
#voyagertherapeutics #huntington #voyager #novartis #vygr #marketsmithcom #adeno #ibddigital #allisongatlin #ibdagatlin